{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:22:05Z","timestamp":1775132525068,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012025","name":"New York University Abu Dhabi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bmcl.2022.128867","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T02:23:14Z","timestamp":1656037394000},"page":"128867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease"],"prefix":"10.1016","volume":"72","author":[{"given":"Davide","family":"Deodato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Asad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128867_b0005","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/ (accessed April 26, 2022)."},{"key":"10.1016\/j.bmcl.2022.128867_b0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10875-021-01190-5","article-title":"Seasonal betacoronavirus antibodies\u2032 expansion post-BNT161b2 vaccination associates with reduced SARS-CoV-2 VoC neutralization","volume":"42","author":"Dispinseri","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bmcl.2022.128867_b0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2022.128867_b0020","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1128\/JVI.75.14.6676-6681.2001","article-title":"Viral replicase gene products suffice for coronavirus discontinuous transcription","volume":"75","author":"Thiel","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2022.128867_b0025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","article-title":"Chemistry and biology of SARS-CoV-2","volume":"6","author":"Domling","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0030","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms and enzymes involved in SARS coronavirus genome expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmcl.2022.128867_b0035","first-page":"1742","article-title":"Design of wide-spectrum inhibitors targeting Coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bmcl.2022.128867_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128867_b0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128867_b0050","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: drug targets and potential treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0055","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2022.128867_b0060","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1205241109","article-title":"Foldon unfolding mediates the interconversion between Mpro-C monomer and 3D domain-swapped dimer","volume":"109","author":"Kang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2022.128867_b0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb Sci"},{"key":"10.1016\/j.bmcl.2022.128867_b0070","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.abf7945","article-title":"X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease","volume":"372","author":"Guenther","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128867_b0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmcl.2022.128867_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved -ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128867_b0085","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128867_b0090","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/acscatal.0c00110","article-title":"Comprehensive insights into the catalytic mechanism of middle east respiratory syndrome 3C-Like protease and severe acute respiratory syndrome 3C-like protease","volume":"10","author":"Wang","year":"2020","journal-title":"ACS Catal"},{"key":"10.1016\/j.bmcl.2022.128867_b0095","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128867_b0100","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128867_b0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.bmcl.2022.128867_b0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbrc.2021.03.096","article-title":"ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model","volume":"555","author":"Vandyck","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2022.128867_b0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128867_b0120","doi-asserted-by":"crossref","first-page":"20697","DOI":"10.1021\/jacs.1c08060","article-title":"Discovery of Di- and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity","volume":"143","author":"Ma","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2022.128867_b0125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128867_b0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-021-20900-6","article-title":"A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"12","author":"Hattori","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128867_b0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111172118","article-title":"DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors","volume":"118","author":"Chamakuri","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2022.128867_b0140","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1021\/acs.jmedchem.1c00665","article-title":"3CL Protease inhibitors with an electrophilic arylketone moiety as anti-SARS-CoV-2 agents","volume":"65","author":"Konno","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cbpa.2008.03.009","article-title":"Peptidomimetics, a synthetic tool of drug discovery","volume":"12","author":"Vagner","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128867_b0150","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.121.000801","article-title":"Disposition of PF-07321332 (Nirmatrelvir), an Orally Bioavailable Inhibitor of SARS-CoV-2 3CL Protease, across Animals and Humans","volume":"50","author":"Eng","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmcl.2022.128867_b0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","article-title":"Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations","volume":"7","author":"Zhang","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.bmcl.2022.128867_b0160","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/acsmedchemlett.0c00521","article-title":"Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2","volume":"11","author":"Ghahremanpour","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128867_b0165","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","article-title":"Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors","volume":"65","author":"Kitamura","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0170","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/acs.jmedchem.1c00598","article-title":"Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CLpro)","volume":"65","author":"Han","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0175","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/jacs.1c08402","article-title":"Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses","volume":"144","author":"Luttens","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2022.128867_b0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0185","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128867_b0190","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1021\/acs.jcim.1c00404","article-title":"Strengths and weaknesses of docking simulations in the SARS-CoV-2 Era: the main protease (Mpro) case study","volume":"61","author":"Llanos","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2022.128867_b0195","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15 - ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2022.128867_b0200","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/ci010025x","article-title":"How does consensus scoring work for virtual library screening? An idealized computer experiment","volume":"41","author":"Wang","year":"2001","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.bmcl.2022.128867_b0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ci700470c","article-title":"Investigation of MM-PBSA rescoring of docking poses","volume":"48","author":"Thompson","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2022.128867_b0210","doi-asserted-by":"crossref","first-page":"eabe0751","DOI":"10.1126\/sciadv.abe0751","article-title":"Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L","volume":"6","author":"Sacco","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmcl.2022.128867_b0215","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128867_b0220","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nprot.2006.77","article-title":"A detergent-based assay for the detection of promiscuous inhibitors","volume":"1","author":"Feng","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmcl.2022.128867_b0225","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:11Z","timestamp":1760773571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"alternative-id":["S0960894X22003432"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128867","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128867"}}